Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: Contribution of UGT1A1, UGT1A8 and UGT1A9

Naoki Kishi, Akane Takasuka, Yuki Kokawa, Takashi Isobe, Maho Taguchi, Masato Shigeyama, Mikio Murata, Manabu Suno, Nobumitsu Hanioka

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

1. Raloxifene is an antiestrogen that has been marketed for the treatment of osteoporosis, and is metabolized into 6- and 4'-glucuronides by UDP-glucuronosyltransferase (UGT) enzymes. In this study, the in vitro glucuronidation of raloxifene in humans and monkeys was examined using liver and intestinal microsomes and recombinant UGT enzymes (UGT1A1, UGT1A8 and UGT1A9).2. Although the Km and CLint values for the 6-glucuronidation of liver and intestinal microsomes were similar between humans and monkeys, and species differences in Vmax values (liver microsomes, humans > monkeys; intestinal microsomes, humans <monkeys) were observed, no significant differences were noted in the Km or S50, Vmax and CLint or CLmax values for the 4'-glucuronidation of liver and intestinal microsomes between humans and monkeys.3. The activities of 6-glucuronidation in recombinant UGT enzymes were UGT1A1 > UGT1A8 >UGT1A9 for humans, and UGT1A8 > UGT1A1 > UGT1A9 for monkeys. The activities of 4'-glucuronidation were UGT1A8 > UGT1A1 > UGT1A9 in humans and monkeys.4. These results demonstrated that the profiles for the hepatic and intestinal glucuronidation of raloxifene by microsomes were moderately different between humans and monkeys.

Original languageEnglish
Pages (from-to)289-295
Number of pages7
JournalXenobiotica
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 2 2016

Fingerprint

Liver Microsomes
Liver
Haplorhini
Glucuronosyltransferase
Microsomes
Estrogen Receptor Modulators
Glucuronides
Enzymes
Osteoporosis
Raloxifene Hydrochloride
UGT1A8 UDP-glucuronosyltransferase
UDP-glucuronosyltransferase 1A9

Keywords

  • Glucuronidation
  • humans
  • intestinal microsomes
  • liver microsomes
  • monkeys
  • raloxifene

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology
  • Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys : Contribution of UGT1A1, UGT1A8 and UGT1A9. / Kishi, Naoki; Takasuka, Akane; Kokawa, Yuki; Isobe, Takashi; Taguchi, Maho; Shigeyama, Masato; Murata, Mikio; Suno, Manabu; Hanioka, Nobumitsu.

In: Xenobiotica, Vol. 46, No. 4, 02.04.2016, p. 289-295.

Research output: Contribution to journalArticle

Kishi, N, Takasuka, A, Kokawa, Y, Isobe, T, Taguchi, M, Shigeyama, M, Murata, M, Suno, M & Hanioka, N 2016, 'Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: Contribution of UGT1A1, UGT1A8 and UGT1A9', Xenobiotica, vol. 46, no. 4, pp. 289-295. https://doi.org/10.3109/00498254.2015.1074301
Kishi, Naoki ; Takasuka, Akane ; Kokawa, Yuki ; Isobe, Takashi ; Taguchi, Maho ; Shigeyama, Masato ; Murata, Mikio ; Suno, Manabu ; Hanioka, Nobumitsu. / Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys : Contribution of UGT1A1, UGT1A8 and UGT1A9. In: Xenobiotica. 2016 ; Vol. 46, No. 4. pp. 289-295.
@article{a01cdd52d9004ec8a9d9e06f7166f09a,
title = "Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: Contribution of UGT1A1, UGT1A8 and UGT1A9",
abstract = "1. Raloxifene is an antiestrogen that has been marketed for the treatment of osteoporosis, and is metabolized into 6- and 4'-glucuronides by UDP-glucuronosyltransferase (UGT) enzymes. In this study, the in vitro glucuronidation of raloxifene in humans and monkeys was examined using liver and intestinal microsomes and recombinant UGT enzymes (UGT1A1, UGT1A8 and UGT1A9).2. Although the Km and CLint values for the 6-glucuronidation of liver and intestinal microsomes were similar between humans and monkeys, and species differences in Vmax values (liver microsomes, humans > monkeys; intestinal microsomes, humans UGT1A8 >UGT1A9 for humans, and UGT1A8 > UGT1A1 > UGT1A9 for monkeys. The activities of 4'-glucuronidation were UGT1A8 > UGT1A1 > UGT1A9 in humans and monkeys.4. These results demonstrated that the profiles for the hepatic and intestinal glucuronidation of raloxifene by microsomes were moderately different between humans and monkeys.",
keywords = "Glucuronidation, humans, intestinal microsomes, liver microsomes, monkeys, raloxifene",
author = "Naoki Kishi and Akane Takasuka and Yuki Kokawa and Takashi Isobe and Maho Taguchi and Masato Shigeyama and Mikio Murata and Manabu Suno and Nobumitsu Hanioka",
year = "2016",
month = "4",
day = "2",
doi = "10.3109/00498254.2015.1074301",
language = "English",
volume = "46",
pages = "289--295",
journal = "Xenobiotica",
issn = "0049-8254",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys

T2 - Contribution of UGT1A1, UGT1A8 and UGT1A9

AU - Kishi, Naoki

AU - Takasuka, Akane

AU - Kokawa, Yuki

AU - Isobe, Takashi

AU - Taguchi, Maho

AU - Shigeyama, Masato

AU - Murata, Mikio

AU - Suno, Manabu

AU - Hanioka, Nobumitsu

PY - 2016/4/2

Y1 - 2016/4/2

N2 - 1. Raloxifene is an antiestrogen that has been marketed for the treatment of osteoporosis, and is metabolized into 6- and 4'-glucuronides by UDP-glucuronosyltransferase (UGT) enzymes. In this study, the in vitro glucuronidation of raloxifene in humans and monkeys was examined using liver and intestinal microsomes and recombinant UGT enzymes (UGT1A1, UGT1A8 and UGT1A9).2. Although the Km and CLint values for the 6-glucuronidation of liver and intestinal microsomes were similar between humans and monkeys, and species differences in Vmax values (liver microsomes, humans > monkeys; intestinal microsomes, humans UGT1A8 >UGT1A9 for humans, and UGT1A8 > UGT1A1 > UGT1A9 for monkeys. The activities of 4'-glucuronidation were UGT1A8 > UGT1A1 > UGT1A9 in humans and monkeys.4. These results demonstrated that the profiles for the hepatic and intestinal glucuronidation of raloxifene by microsomes were moderately different between humans and monkeys.

AB - 1. Raloxifene is an antiestrogen that has been marketed for the treatment of osteoporosis, and is metabolized into 6- and 4'-glucuronides by UDP-glucuronosyltransferase (UGT) enzymes. In this study, the in vitro glucuronidation of raloxifene in humans and monkeys was examined using liver and intestinal microsomes and recombinant UGT enzymes (UGT1A1, UGT1A8 and UGT1A9).2. Although the Km and CLint values for the 6-glucuronidation of liver and intestinal microsomes were similar between humans and monkeys, and species differences in Vmax values (liver microsomes, humans > monkeys; intestinal microsomes, humans UGT1A8 >UGT1A9 for humans, and UGT1A8 > UGT1A1 > UGT1A9 for monkeys. The activities of 4'-glucuronidation were UGT1A8 > UGT1A1 > UGT1A9 in humans and monkeys.4. These results demonstrated that the profiles for the hepatic and intestinal glucuronidation of raloxifene by microsomes were moderately different between humans and monkeys.

KW - Glucuronidation

KW - humans

KW - intestinal microsomes

KW - liver microsomes

KW - monkeys

KW - raloxifene

UR - http://www.scopus.com/inward/record.url?scp=84956939513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956939513&partnerID=8YFLogxK

U2 - 10.3109/00498254.2015.1074301

DO - 10.3109/00498254.2015.1074301

M3 - Article

C2 - 26247833

AN - SCOPUS:84956939513

VL - 46

SP - 289

EP - 295

JO - Xenobiotica

JF - Xenobiotica

SN - 0049-8254

IS - 4

ER -